Download PDF
Rofo 2019; 191(04): 323-332
DOI: 10.1055/a-0715-2205
Review
© Georg Thieme Verlag KG Stuttgart · New York

Radiological Diagnosis of Soft Tissue Tumors in Adults: MRI Imaging of Selected Entities Delineating Benign and Malignant Tumors

Article in several languages: English | deutsch
Catharina Silvia Lisson
  Department of Diagnostic and Interventional Radiology, University-Hospital of Ulm, Germany
,
Christoph Gerhard Lisson
  Department of Diagnostic and Interventional Radiology, University-Hospital of Ulm, Germany
,
Meinrad Beer
  Department of Diagnostic and Interventional Radiology, University-Hospital of Ulm, Germany
,
Stefan Andreas Schmidt
  Department of Diagnostic and Interventional Radiology, University-Hospital of Ulm, Germany
› Author Affiliations
Further Information

Publication History

19 February 2018

11 August 2018

Publication Date:
18 December 2018 (online)

Also available at
   Permissions and Reprints

Abstract

Objective MRI is the most important and sensitive imaging modality in the differentiation of unclear soft tissue tumors. A systematic approach helps to narrow down the large number of possible differential diagnoses.

Method Our review systematically compares MRI characteristics of the major soft-tissue masses and aims to gain access to these often difficult tumor entities.

Results and conclusion MRI, as the most important modality in the imaging of soft tissue tumors, allows a more detailed classification of the tumor entity and in many cases a differentiation between benign and malignant masses.

Key points: 

  • MRI is the method of choice for classifying unclear soft tissue tumors.

  • A systematic approach may differentiate benign from unclear lesions.

  • In cases of doubt, a biopsy should be performed to rule out malignancy.

Citation Format

  • Lisson CS, Lisson CG, Beer M et al. Radiological Diagnosis of Soft Tissue Tumors in Adults: MRI Imaging of Selected Entities Delineating Benign and Malignant Tumors. Fortschr Röntgenstr 2019; 191: 323 – 332

Key words

muscular - skeletal-appendicular - skeletal-axial - soft tissues - neoplasms
 

  • Literatur

  • 1 Breitenseher M. Bildgebende Diagnostik und Therapie der Weichteiltumoren: mit pathologischer Klassifikation, Nuklearmedizin, interventioneller Therapie; 21 Tabellen. Thieme; 2008
    PubMedGoogle Scholar
  • 2 Bannasch H, Eisenhardt SU, Grosu AL. et al. The diagnosis and treatment of soft tissue sarcomas of the limbs. Deutsches Arzteblatt international 2011; 108: 32-38
    PubMedGoogle Scholar
  • 3 Murphey MD, Carroll JF, Flemming DJ. et al. From the archives of the AFIP: benign musculoskeletal lipomatous lesions. Radiographics 2004; 24: 1433-1466
    CrossrefPubMedGoogle Scholar
  • 4 Kransdorf MJ, Bancroft LW, Peterson JJ. et al. Imaging of fatty tumors: distinction of lipoma and well-differentiated liposarcoma. Radiology 2002; 224: 99-104
    CrossrefPubMedGoogle Scholar
  • 5 Bancroft LW, Kransdorf MJ, Peterson JJ. et al. Benign fatty tumors: classification, clinical course, imaging appearance, and treatment. Skeletal radiology 2006; 35: 719-733
    CrossrefPubMedGoogle Scholar
  • 6 Goldblum JR, Weiss SW, Folpe AL. Enzinger and Weiss's Soft Tissue Tumors E-Book. Elsevier Health Sciences; 2013
    Google Scholar
  • 7 Jelinek JS, Kransdorf MJ, Shmookler BM. et al. Liposarcoma of the extremities: MR and CT findings in the histologic subtypes. Radiology 1993; 186: 455-459
    CrossrefPubMedGoogle Scholar
  • 8 Zhang H, Erickson-Johnson M, Wang X. et al. Molecular testing for lipomatous tumors: critical analysis and test recommendations based on the analysis of 405 extremity-based tumors. Am J Surg Pathol 2010; 34: 1304-1311
    CrossrefPubMedGoogle Scholar
  • 9 Wang XL, De Schepper AM, Vanhoenacker F. et al. Nodular fasciitis: correlation of MRI findings and histopathology. Skeletal radiology 2002; 31: 155-161
    CrossrefPubMedGoogle Scholar
  • 10 Fletcher CDM, Unni KK, Mertens F. et al. Pathology and Genetics of Tumours of Soft Tissue and Bone. IARC Press; 2002
    PubMedGoogle Scholar
  • 11 Crundwell N, O'Donnell P, Saifuddin A. Non-neoplastic conditions presenting as soft-tissue tumours. Clinical radiology 2007; 62: 18-27
    CrossrefPubMedGoogle Scholar
  • 12 Parikh J, Hyare H, Saifuddin A. The imaging features of post-traumatic myositis ossificans, with emphasis on MRI. Clinical radiology 2002; 57: 1058-1066
    CrossrefPubMedGoogle Scholar
  • 13 Kransdorf MJ, Meis JM. From the archives of the AFIP. Extraskeletal osseous and cartilaginous tumors of the extremities. Radiographics 1993; 13: 853-884
    CrossrefPubMedGoogle Scholar
  • 14 Jackson DW. Managing Myositis Ossificans in the Young Athlete. Physician and Sportsmedicine 1975; 3: 56-61
    CrossrefPubMedGoogle Scholar
  • 15 Berlien H, Poetke M, Philipp C. et al. Phakomatosen. In: Oldhafer M. Hrsg Transitionsmedizin. Stuttgart: Schattauer; 2015: 169-180
    Google Scholar
  • 16 International Society for the Study of Vascular Anomalies. ISSVA classification for vascular anomalies (Approved at the 20th ISSVA Workshop, Melbourne, April 2014, last revision May 2018). Available via http://www.issva.org/UserFiles/file/ISSVA-Classification-2018.pdf . Accessed 7 Jul 2018
    PubMedGoogle Scholar
  • 17 Berlien H, Urban P, Poetke M. et al. Klassifikation der Vaskulären Malformationen. Phlebologie 2016; 45: 295-303
    Article in Thieme ConnectPubMedGoogle Scholar
  • 18 Kransdorf MJ, Murphey MD. Imaging of Soft Tissue Tumors. Lippincott Williams & Wilkins; 2006
    Google Scholar
  • 19 Vilanova JC, Barcelo J, Smirniotopoulos JG. et al. Hemangioma from head to toe: MR imaging with pathologic correlation. Radiographics 2004; 24: 367-385
    CrossrefPubMedGoogle Scholar
  • 20 Murphey MD, Fairbairn KJ, Parman LM. et al. From the archives of the AFIP. Musculoskeletal angiomatous lesions: radiologic-pathologic correlation. Radiographics 1995; 15: 893-917
    CrossrefPubMedGoogle Scholar
  • 21 Papp DF, Khanna AJ, McCarthy EF. et al. Magnetic resonance imaging of soft-tissue tumors: determinate and indeterminate lesions. The Journal of bone and joint surgery American volume 2007; 89 (Suppl. 03) 103-115
    PubMedGoogle Scholar
  • 22 Myers BW, Masi AT. Pigmented villonodular synovitis and tenosynovitis: a clinical epidemiologic study of 166 cases and literature review. Medicine (Baltimore) 1980; 59: 223-238
    PubMedGoogle Scholar
  • 23 Dorwart RH, Genant HK, Johnston WH. et al. Pigmented villonodular synovitis of synovial joints: clinical, pathologic, and radiologic features. Am J Roentgenol 1984; 143: 877-885
    CrossrefPubMedGoogle Scholar
  • 24 Al-Nakshabandi NA, Ryan AG, Choudur H. et al. Pigmented villonodular synovitis. Clinical radiology 2004; 59: 414-420
    CrossrefPubMedGoogle Scholar
  • 25 Cotten A, Flipo RM, Chastanet P. et al. Pigmented villonodular synovitis of the hip: review of radiographic features in 58 patients. Skeletal radiology 1995; 24: 1-6
    CrossrefPubMedGoogle Scholar
  • 26 Llauger J, Palmer J, Roson N. et al. Pigmented villonodular synovitis and giant cell tumors of the tendon sheath: radiologic and pathologic features. Am J Roentgenol 1999; 172: 1087-1091
    CrossrefPubMedGoogle Scholar
  • 27 Karasick D, Karasick S. Giant cell tumor of tendon sheath: spectrum of radiologic findings. Skeletal radiology 1992; 21: 219-224
    PubMedGoogle Scholar
  • 28 De Beuckeleer L, De Schepper A, De Belder F. et al. Magnetic resonance imaging of localized giant cell tumour of the tendon sheath (MRI of localized GCTTS). Eur Radiol 1997; 7: 198-201
    CrossrefPubMedGoogle Scholar
  • 29 Murphey MD, Rhee JH, Lewis RB. et al. Pigmented villonodular synovitis: radiologic-pathologic correlation. Radiographics 2008; 28: 1493-1518
    CrossrefPubMedGoogle Scholar
  • 30 Kransdorf MJ. Benign soft-tissue tumors in a large referral population: distribution of specific diagnoses by age, sex, and location. Am J Roentgenol 1995; 164: 395-402
    CrossrefPubMedGoogle Scholar
  • 31 Banks KP. The target sign: extremity. Radiology 2005; 234: 899-900
    CrossrefPubMedGoogle Scholar
  • 32 Murphey MD, Smith WS, Smith SE. et al. From the archives of the AFIP. Imaging of musculoskeletal neurogenic tumors: radiologic-pathologic correlation. Radiographics 1999; 19: 1253-1280
    CrossrefPubMedGoogle Scholar
  • 33 Kalayanarooj S. Benign and malignant soft tissue mass: magnetic resonance imaging criteria for discrimination. J Med Assoc Thai 2008; 91: 74-81
    PubMedGoogle Scholar
  • 34 Enochs WS, Hyslop WB, Bennett HF. et al. Sources of the increased longitudinal relaxation rates observed in melanotic melanoma. An in vitro study of synthetic melanins. Invest Radiol 1989; 24: 794-804
    CrossrefPubMedGoogle Scholar
  • 35 White LM, Schweitzer ME, Khalili K. et al. MR imaging of primary lymphoma of bone: variability of T2-weighted signal intensity. Am J Roentgenol 1998; 170: 1243-1247
    CrossrefPubMedGoogle Scholar
  • 36 Sundaram M, McGuire MH, Schajowicz F. Soft-tissue masses: histologic basis for decreased signal (short T2) on T2-weighted MR images. Am J Roentgenol 1987; 148: 1247-1250
    CrossrefPubMedGoogle Scholar
  • 37 Dinauer PA, Brixey CJ, Moncur JT. et al. Pathologic and MR imaging features of benign fibrous soft-tissue tumors in adults. Radiographics 2007; 27: 173-187
    CrossrefPubMedGoogle Scholar
  • 38 Martinez S, Vogler 3rd JB, Harrelson JM. et al. Imaging of tumoral calcinosis: new observations. Radiology 1990; 174: 215-222
    CrossrefPubMedGoogle Scholar
  • 39 Harish S, Lee JC, Ahmad M. et al. Soft tissue masses with “cyst-like” appearance on MR imaging: Distinction of benign and malignant lesions. Eur Radiol 2006; 16: 2652-2660
    CrossrefPubMedGoogle Scholar
  • 40 Stiskal MA, Neuhold A, Szolar DH. et al. Rheumatoid arthritis of the craniocervical region by MR imaging: detection and characterization. Am J Roentgenol 1995; 165: 585-592
    CrossrefPubMedGoogle Scholar
  • 41 Kransdorf MJ, Murphey MD. Radiologic evaluation of soft-tissue masses: a current perspective. Am J Roentgenol 2000; 175: 575-587
    CrossrefPubMedGoogle Scholar
  • 42 Ma LD, McCarthy EF, Bluemke DA. et al. Differentiation of benign from malignant musculoskeletal lesions using MR imaging: pitfalls in MR evaluation of lesions with a cystic appearance. Am J Roentgenol 1998; 170: 1251-1258
    CrossrefPubMedGoogle Scholar
  • 43 Frassica FJ, Khanna JA, McCarthy EF. The role of MR imaging in soft tissue tumor evaluation: perspective of the orthopedic oncologist and musculoskeletal pathologist. Magn Reson Imaging Clin N Am 2000; 8: 915-927
    PubMedGoogle Scholar
  • 44 Ma LD, Frassica FJ, Scott Jr WW. et al. Differentiation of benign and malignant musculoskeletal tumors: potential pitfalls with MR imaging. Radiographics 1995; 15: 349-366
    CrossrefPubMedGoogle Scholar
  • 45 Sundaram M, Sharafuddin MJ. MR imaging of benign soft-tissue masses. Magn Reson Imaging Clin N Am 1995; 3: 609-627
    PubMedGoogle Scholar
  • 46 Jelinek J, Kransdorf MJ. MR imaging of soft-tissue masses. Mass-like lesions that simulate neoplasms. Magnetic Resonance Imaging Clinics of North America 1995; 3: 727-741
    PubMedGoogle Scholar
  • 47 Beggs I. Pictorial review: imaging of peripheral nerve tumours. Clinical radiology 1997; 52: 8-17
    CrossrefPubMedGoogle Scholar
  • 48 Blacksin MF, Siegel JR, Benevenia J. et al. Synovial sarcoma: frequency of nonaggressive MR characteristics. J Comput Assist Tomogr 1997; 21: 785-789
    CrossrefPubMedGoogle Scholar
  • 49 Tateishi U, Hasegawa T, Beppu Y. et al. Prognostic significance of MRI findings in patients with myxoid-round cell liposarcoma. Am J Roentgenol 2004; 182: 725-731
    CrossrefPubMedGoogle Scholar
  • 50 Misra A, Mistry N, Grimer R. et al. The management of soft tissue sarcoma. J Plast Reconstr Aesthet Surg 2009; 62: 161-174
    CrossrefPubMedGoogle Scholar
  • 51 Verstraete KL, De Deene Y, Roels H. et al. Benign and malignant musculoskeletal lesions: dynamic contrast-enhanced MR imaging--parametric "first-pass" images depict tissue vascularization and perfusion. Radiology 1994; 192: 835-843
    CrossrefPubMedGoogle Scholar
  • 52 van der Woude HJ, Verstraete KL, Hogendoorn PC. et al. Musculoskeletal tumors: does fast dynamic contrast-enhanced subtraction MR imaging contribute to the characterization?. Radiology 1998; 208: 821-828
    CrossrefPubMedGoogle Scholar
  • 53 Kettelhack C, Wickede M, Vogl T. et al. 31Phosphorus-magnetic resonance spectroscopy to assess histologic tumor response noninvasively after isolated limb perfusion for soft tissue tumors. Cancer 2002; 94: 1557-1564
    CrossrefPubMedGoogle Scholar
  • 54 Einarsdottir H, Karlsson M, Wejde J. et al. Diffusion-weighted MRI of soft tissue tumours. Eur Radiol 2004; 14: 959-963
    CrossrefPubMedGoogle Scholar
  • 55 Dudeck O, Zeile M, Pink D. et al. Diffusion-weighted magnetic resonance imaging allows monitoring of anticancer treatment effects in patients with soft-tissue sarcomas. J Magn Reson Imaging 2008; 27: 1109-1113
    CrossrefPubMedGoogle Scholar
  • 56 Burrell RA, McGranahan N, Bartek J. et al. The causes and consequences of genetic heterogeneity in cancer evolution. Nature 2013; 501: 338-345
    PubMedGoogle Scholar
  • 57 Lisson CS, Lisson CG, Flosdorf K. et al. Diagnostic value of MRI-based 3D texture analysis for tissue characterisation and discrimination of low-grade chondrosarcoma from enchondroma: a pilot study. Eur Radiol 2018; 28: 468-477
    CrossrefPubMedGoogle Scholar